Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
COVID-19
100%
Metabolic Surgery
100%
Nonalcoholic Steatohepatitis
87%
Confidence Interval
75%
Odds Ratio
75%
Hospitalization Risk
50%
Metabolic Syndrome
25%
Bariatric Surgery
25%
Metabolic Disease
25%
Significant Risk Factors
25%
Statin Use
25%
Metformin Use
25%
Missing Data
12%
Inflammation
12%
Midwest
12%
Risk Reduction
12%
Obesity
12%
Health Systems
12%
Multi-ethnic
12%
Visceral Adipose Tissue
12%
Venous Thromboembolism
12%
Socioeconomic Status
12%
Thrombosis
12%
Comorbidity
12%
Hospitalization
12%
Chronic Inflammation
12%
Retrospective Analysis
12%
Receptor Agonist
12%
COVID-19 Diagnosis
12%
SARS-CoV-19
12%
Medication Treatment
12%
Polymerase Chain Reaction
12%
Polymerase Chain Reaction Assay
12%
A1 Receptor
12%
Cause of Disease
12%
Decreased Risk
12%
Least Absolute Shrinkage and Selection Operator (LASSO)
12%
Multivariable Logistic Regression
12%
Glucagon-like
12%
Risk Model
12%
Multiple Imputation
12%
Metabolic Therapy
12%
Operator Method
12%
COVID-19 Disease
12%
Mitigating Effect
12%
COVID-19 Inpatients
12%
Electronic Medical Record Data
12%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
COVID-19
100%
Odds Ratio
40%
Statin
13%
Water-Electrolyte Imbalance
13%
Metabolic Syndrome
13%
Glycon
13%
Polymerase Chain Reaction
13%
Bariatric Surgery
13%
Disease
6%
Obesity
6%
Observational Study
6%
Drug Therapy
6%
Electronic Patient Record
6%
Thrombosis
6%
Socioeconomic Status
6%
Venous Thromboembolism
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Logistic Regression Analysis
6%
Chronic Inflammation
6%
Glucagon-Like Peptide-1 Agonist
6%
Nursing and Health Professions
Nonalcoholic Fatty Liver
100%
Odds Ratio
40%
Confidence Interval
40%
Metabolic Syndrome X
13%
Bariatric Surgery
13%
Statin (Protein)
13%
Metabolic Disorder
13%
Metformin
13%
Polymerase Chain Reaction
13%
Socioeconomic Status
6%
Inflammation
6%
Electronic Medical Record
6%
Glucagon Like Peptide 1 Receptor Agonist
6%
Severe Acute Respiratory Syndrome
6%
Healthcare System
6%
Drug Therapy
6%
Obesity
6%
Logistic Regression Analysis
6%
Chronic Inflammation
6%
Venous Thromboembolism
6%
Disease
6%
Thrombosis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Metabolic Syndrome X
13%
Statin (Protein)
13%
Metformin
13%
Metabolic Disorder
13%
Observational Study
6%
Obesity
6%
Venous Thromboembolism
6%
SARS Coronavirus
6%
Glucagon Like Peptide 1 Receptor Agonist
6%
Chronic Inflammation
6%
Inflammation
6%
Disease
6%
Thrombosis
6%